Skip to main content
Johnson & Johnson8-K: Margin pressure

J&J lowers 2026 EPS guidance by $0.64 and cuts operating margin outlook by ~150 bps after acquisitions.

What happened

The acquisition of Firefly Bio and a new collaboration with Sail Biomedicines will significantly impact short-term profitability, reducing 2026 adjusted EPS by $0.64. This creates immediate pressure on the organization to find operational efficiencies and cost savings to offset the dilutive effect of these strategic R&D investments.

Source

SEC EDGARJul 29, 2026

Current report (Form 8-K)

Johnson & Johnson 8-K

Filing excerpt

The combination of these two transactions is expected to reduce the Company’s adjusted operational earnings per share (Adjusted Operational EPS) and adjusted earnings per share (Adjusted EPS) by approximately $0.64 in 2026...

sec.gov/Archives/edgar/data/200406/000020040626000163/jnj-20260729.htmRead the full source

Other signals in this filing (2)

Extracted by Autobound

From the Signal API record
Signal
8-K: Margin pressure

What this signalsFilings often name leadership changes, deals and spending plans.

Form
8-K
Fiscal year end
07/29
Filed
Jul 29, 2026

The full record

From the Signal API record

Numbers

PercentDecrease in adjusted pre-tax operating margin vs. prior guidance (150 bps).
1.5%

Details

CIK
200406
Accession number
0000200406-26-000163
Timeframe
Immediate
Filing year
2026
Why it matters
Efficiency tools needed
Signal category
Financial

Topics and mentions

Vendors

  • Firefly Bio
  • Inc.
  • Sail Biomedicines

Vendors named

  • Firefly Bio, Inc.
  • Sail Biomedicines

Extraction

Confidence
High
Relevance
90%
Sentiment
Negative
Detected
Aug 4, 2026
signal_type
sec-8k
signal_subtype
marginPressure

Use this data

Get every 8-K signal for Johnson & Johnson and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Johnson & Johnson this week?”

  2. Send it to your own tools

    The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/2415377d-a156-4738-973e-f816f9f912c0 returns this record as JSON. POST /v1/companies/enrich returns every signal for jnj.com.

{
  "signal_id": "2415377d-a156-4738-973e-f816f9f912c0",
  "signal_type": "sec-8k",
  "signal_subtype": "marginPressure",
  "detected_at": "2026-08-04T07:04:43.208+00:00",
  "company": {
    "name": "Johnson & Johnson",
    "domain": "jnj.com"
  },
  "data": {
    "detail": "The acquisition of Firefly Bio and a new collaboration with Sail Biomedicines will significantly impact short-term profitability, reducing 2026 adjusted EPS by $0.64. This creates immediate pressure on the organization to find operational efficiencies and cost savings to offset the dilutive effect of these strategic R&D investments.",
    "metrics": {
      "pct": 1.5,
      "timeframe": "immediate",
      "pct_context": "Decrease in adjusted pre-tax operating margin vs. prior guidance (150 bps).",
      "dollar_context": "The filing specifies a $0.64 reduction in earnings per share, not a total dollar amount."
    },
    "summary": "J&J lowers 2026 EPS guidance by $0.64 and cuts operating margin outlook by ~150 bps after acquisitions.",
    "excerpts": "The combination of these two transactions is expected to reduce the Company’s adjusted operational earnings per share (Adjusted Operational EPS) and adjusted earnings per share (Adjusted EPS) by approximately $0.64 in 2026...",
    "relevance": 0.9,
    "sentiment": "negative",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/200406/000020040626000163/jnj-20260729.htm",
    "filing_date": "2026-07-29",
    "filing_year": 2026,
    "fiscal_year_end": "07/29",
    "sales_relevance": "Efficiency tools needed",
    "signal_category": "financial",
    "vendors_mentioned": [
      "Firefly Bio, Inc.",
      "Sail Biomedicines"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.